In this episode European Pharmaceutical Manufacturer secured an interview with Dr. Andreas Raabe CEO at Adragos Pharma. 

In this insightful discussion, we look at what it takes to be a leader in the pharmaceutical industry.

Leaders in Pharma: Adragos Pharma

Precision medicine is an innovative approach that helps your doctor find your unique disease
risks for tailoring disease treatment and prevention. Most medical treatments are designed
for the "average patient" as a one-size-fits-all-approach, which may be successful for some
patients but not for others. Precision medicine allows doctors and researchers to more
accurately predict which treatments are more likely to work for a patient, taking into account
individual genetic and molecular make-up, environment, and lifestyle. The goal of precision
medicine is to target the right treatments to the right patients at the right time.

PRECISION MEDICINE

Learn about why commercial insurance is going through the roof with an industry expert, and learn what you can do to protect yourself from loss! Frederick will give you tips and advice on how to deal with insurance. 

Understanding Commercial Insurance: Frederick Knight V (Life Science Insurance Broker)

F4KEB0DY B2B SPARKY @ MEL'S HOLE

Pink Sheet reporter and editors discuss potential threats to the COVID-19 vaccine pediatric indications under the Trump Administration (:24), the DOGE commission’s search for spending cuts and its impact on the FDA (12:52), as well as a new 340B rebate pricing model that some pharma companies are implementing to contain the program’s costs (22:52).

More On These Topics From The Pink Sheet

Pediatric COVID Shots, Still Under EUA, Would Be Vulnerable In Anti-Vax HHS: https://insights.citeline.com/pink-sheet/vaccines/pediatric-covid-shots-still-under-eua-would-be-vulnerable-in-anti-vax-hhs-UWJRLYQUCJEWTLC42IFR7X2XFY/ 

Can US FDA Dodge DOGE? Return To Office Mandate May Be Biggest Hit: https://insights.citeline.com/pink-sheet/legislation/elections/can-us-fda-dodge-doge-return-to-office-mandate-may-be-biggest-hit-5G5SYM3ACNAKLHSSHQL32KJN5Y/ 

340B Plan B: Pharma Pivots To Rebate Pricing Model After Pharmacy Restrictions Fall Short: https://insights.citeline.com/pink-sheet/market-access/pricing-debate/340b-plan-b-pharma-pivots-to-rebate-pricing-model-after-pharmacy-restrictions-fall-short-M5DTVTFXVZA37IQ6CXMTDW4QMI/ 


Drug Fix: COVID-19 Vaccine EUAs In Danger, DOGE And US FDA, New 340B Rebate Pricing Models

Progressives blame the free market for insulin prices and want to impose price controls. But, government regulation is to blame.

Narrated by Millian Quinteros.

Audio Mises Wire

How the Government Created Exorbitant Insulin Prices | Isaac Deak

AmpleLogic Asset Management Software revolutionizes equipment calibration and preventive maintenance. Streamline detailed processes with the COTS solution. The Asset Management Software ensures robust scheduling, enhances real-time visibility and compliance with regulatory standards. Elevate your calibration experience with AmpleLogic AMS.


AmpleLogic Asset Management System

Welcome to today’s podcast! Let’s dive into Third Party Manufacturing in Pharma, a game-changer for the pharmaceutical industry. This model allows companies to outsource production to GMP-WHO-certified manufacturers, ensuring top-quality products without the burden of owning a production facility. It’s ideal for startups and established businesses looking to expand their product portfolio while cutting costs. With third-party manufacturing, companies can focus on marketing and distribution while leaving the complexities of production to experts. This partnership promotes scalability, efficiency, and innovation in the growing pharma sector. Stay tuned for more insights into industry trends and opportunities.

Third Party Manufacturing in Pharma

aldim onu yeni
gozleriyle bagımlı etti kendine
baştan assa mukemmelsin nasıl olur dengı
bae ilacım gibi mutlu eder benı

tek amacım sensin
bebek kolay gelsin
yeni hayatında başarılar
aşamam önümde dağlar
kafamda karmaşa hakim
uyuyorum planına bebeğim sakin
o kadar ugrastım yıne de gıttın
ilac almamın sebebı sensın

bagımlılıgın kotu yanları

Finally, some good news about innovation, change and transformation, at a time of extraordinary change in pharma.  

Based on extensive research, this book tells the story of how some leaders are re-vitalizing they way their organizations execute on strategy. They are putting the 'super' back in their biggest projects and initiatives.

Super Projects is slightly different (more upbeat) take on transformation initiatives & change programs from the front lines in big pharma. It provides leaders with the inspiration and tools they need to double down on the level of confidence in their own big projects and initiatives.

Join the authors at https://www.linkedin.com/in/raycollis/

Pharma Super Projects

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

DDE is constantly working to provide smarter technologies, systems and solutions to healthcare companies. For the last 30 years, our focus has been to develop smarter innovations. Today, DDE houses 350+ engineers, technicians, designers, biotechnologists, researchers and experts working at the intersection of technology and healthcare sciences to solve some of the industry’s toughest problems.

A podcast covering the latest news and conversations in life sciences brought to you by the editors of Med-Tech Innovation News, Medical Plastics News and European Pharmaceutical Manufacturer.
Now featuring the FemTech Series!

The Mises Institute, founded in 1982, is an educational institution devoted to advancing Austrian economics, freedom, and peace in the classical-liberal tradition. Our website offers many thousands of free books and thousands of hours of audio and video, along with the full run of rare journals, biographies, and bibliographies of great economists.

What is it going to take to bring your strategy to life? Given the level of ambition involved, the standard approach is unlikely to be enough. It is going to take a Super Project to make it happen!

Welcome to the BETA version, we are making it available early to stimulate the conversation and input to the launch Super Projects in full.

Bringing top professionals in the commercial real estate industry to present insights and discuss their views on the market today. We aim to have topics that are both interesting to people new to real estate and seasoned professionals looking to enhance their practice.

New tracks tagged #pharma